Effects of General Anesthesia on Quality of Recovery After Transaxillary Endoscopic Breast Augmentation

Chih-Cheng Hung

Status: Completed

Conditions: Quality of Recovery; Total Intravenous Anesthesia; Breast Augmentation; Inhalation Anesthesia

Treatments: Drug: Propofol; Drug: Desflurane

Study type: Interventional

Funder types: Other

Identifiers

NCT04036487

CMTMU201701

Details and patient eligibility

About

Among aesthetic or cosmetic surgeries, breast augmentation was the most frequently performed and the endoscopic transaxillary approach has become the preferred incision for Asian women. As breast augmentation must be performed under general anesthesia accompanied by its effects and potential complications, types of general anesthesia may affect the quality of recovery. Currently, the two most common techniques of general anesthesia are inhalation anesthesia (IH) and total intravenous anesthesia (TIVA). The effects of these types of general anesthesia on the quality of recovery have been investigated for numerous surgical procedures. However, no prior studies have analyzed different types of anesthesia used for performing transaxillary endoscopic breast augmentation. This prospective, parallel, randomized controlled study will evaluate the effects of inhalation anesthesia vs. total intravenous anesthesia on the quality of recovery in patients undergoing transaxillary endoscopic breast augmentation.

Enrollment: 104 patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients are appropriate for undergoing transaxillary endoscopic breast augmentation
• Age between 20-65 years
• Physical Status I or II as defined by the American Society of Anesthesiologists (ASA) Physical Status Classification System

Exclusion criteria

• Having difficulty reading or hearing
• Diagnosed with addictive disorder
• Diagnosed with psychiatric disorder
• Physical Status III-VI as defined by the ASA Physical Status Classification System
• Presence of acute infection or inflammatory condition (e.g., fever).

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

104 participants in 2 patient groups

IH group

Experimental group

Description:

Inhalation anesthesia will be given during transaxillary endoscopic breast augmentation.

Treatment:

Drug: Desflurane

TIVA group

Active Comparator group

Description:

Total intravenous anesthesia will be given during transaxillary endoscopic breast augmentation.

Treatment:

Drug: Propofol